Cita APA

Onofrio, L. I., Alamino, V. A., Ferrero, P. V., Montes, C. L., Gruppi, A., Acosta Rodriguez, E. V., . . . Cadile, I. I. (2022). The JAK inhibitor tofacitinib activates immunosenescence pathways and limits activation and function of T lymphocytes. Web

Citación estilo Chicago

Onofrio, Luisina Ines, Vanina Alejandra Alamino, Paola Virginia Ferrero, Carolina Lucía Montes, Adriana Gruppi, Eva Virginia Acosta Rodriguez, Marina Werner, Laura Beatriz Onetti, and Isaac Ignacio Cadile. The JAK Inhibitor Tofacitinib Activates Immunosenescence Pathways and Limits Activation and Function of T Lymphocytes. 2022.

Cita MLA

Onofrio, Luisina Ines, et al. The JAK Inhibitor Tofacitinib Activates Immunosenescence Pathways and Limits Activation and Function of T Lymphocytes. 2022.

Precaución: Estas citas no son 100% exactas.